| Medicinal product name | Axetine 250 mg film-coated tablets |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Film-coated tablet | ||||||
| Strength | 250 mg | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Reimbursed medicines reference product |
||||||
| Package leaflet |  13-07-2023
|
||||||
| Summary of product characteristics | 13-07-2023
|
||||||
| ATC code | J01DC02 – Antibacterials for systemic use | ||||||
| Information for Marketing authorisation holders | View |
Medicinal products (15)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10: 1 × 10 (250 mg) |
PVC/PVDC/Al blister | 10-0629-01 |
 Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20: 2 × 10 (250 mg) |
PVC/PVDC/Al blister | 10-0629-02 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30: 3 × 10 (250 mg) |
PVC/PVDC/Al blister | 10-0629-03 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50: 5 × 10 (250 mg) |
PVC/PVDC/Al blister | 10-0629-04 |
Labelling text Jun 14, 2018 |
|
|
Is available (according to the information provided by wholesalers) (105 containers) |
Magnum Medical |
N10: 1 × 10 (250 mg) |
Al/Al blister |
€ 5.67 * |
10-0629-05 |
Labelling text Jun 14, 2018 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20: 2 × 10 (250 mg) |
Al/Al blister | 10-0629-06 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30: 3 × 10 (250 mg) |
Al/Al blister | 10-0629-07 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50: 5 × 10 (250 mg) |
Al/Al blister | 10-0629-08 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14: 2 × 7 (250 mg) |
PVC/PVDC/Al blister | 10-0629-09 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14: 2 × 7 (250 mg) |
Al/Al blister | 10-0629-10 |
Labelling text Jun 14, 2018 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10: 1 × 10 (250 mg) |
Al/Al | 10-0629-11 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20: 2 × 10 (250 mg) |
Al/Al | 10-0629-12 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30: 3 × 10 (250 mg) |
Al/Al | 10-0629-13 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50: 5 × 10 (250 mg) |
Al/Al | 10-0629-14 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14: 2 × 7 (250 mg) |
Al/Al | 10-0629-15 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 10-0629 |
|---|---|
| Date of authorisation | Dec 30, 2010 |
| Marketing authorisation holder, country | Medochemie Ltd., Cyprus |
